Exact Mass: 1092.4639694
Exact Mass Matches: 1092.4639694
Found 14 metabolites which its exact mass value is equals to given mass value 1092.4639694,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
(25R)-2alpha,3beta-dihydroxy-5alpha-spirost-9-en-12-one 3-O-2)-O-3)>-O-beta-D-glucopyranosyl-(1<*>4)-beta-D-galactopyranoside>|(25R)-2alpha,3beta-dihydroxy-5alpha-spirost-9-en-12-one3-O-{O-beta-D-glucopyranosyl-(1[*]2)-O-[beta-D-glucopyranosyl-(1[*]3)]-O-beta-D-glucopyranosyl-(1[*]4)-beta-D-galactopyranoside}
(25R)-2alpha,3beta-dihydroxy-5alpha-spirost-9-en-12-one 3-O-2)-O-3)>-O-beta-D-glucopyranosyl-(1<*>4)-beta-D-galactopyranoside>|(25R)-2alpha,3beta-dihydroxy-5alpha-spirost-9-en-12-one3-O-{O-beta-D-glucopyranosyl-(1[*]2)-O-[beta-D-glucopyranosyl-(1[*]3)]-O-beta-D-glucopyranosyl-(1[*]4)-beta-D-galactopyranoside}
Mca-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 trifluoroacetate salt
Mca-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 trifluoroacetate salt
KSPWFTTL (TFA)
KSPWFTTL (TFA)
C50H71F3N10O14 (1092.5103061999998)
KSPWFTTL TFA is an immunodominant Kb-restricted epitope from the p15E transmembrane protein. KSPWFTTL TFA can restore susceptibility of a tumor line to anti-AKR/Gross MuLV cytotoxic T lymphocytes[1][2].
n-[15-(3-carbamimidamidopropyl)-6,13,16,21-tetrahydroxy-2-(1-hydroxyethyl)-5-[(4-hydroxyphenyl)methyl]-4,11-dimethyl-3,9,22-trioxo-8-(sec-butyl)-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2-{[1,2-dihydroxy-3-(sulfooxy)propylidene]amino}-3-(4-hydroxyphenyl)propanimidic acid
n-[15-(3-carbamimidamidopropyl)-6,13,16,21-tetrahydroxy-2-(1-hydroxyethyl)-5-[(4-hydroxyphenyl)methyl]-4,11-dimethyl-3,9,22-trioxo-8-(sec-butyl)-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2-{[1,2-dihydroxy-3-(sulfooxy)propylidene]amino}-3-(4-hydroxyphenyl)propanimidic acid
C47H68N10O18S (1092.4433548000002)
(1's,2r,2's,4's,5r,7's,8'r,9's,13's,15'r,16'r,18's)-16'-{[(2r,3r,4r,5r,6r)-3,4-dihydroxy-5-{[(2s,3r,4s,5r,6r)-5-hydroxy-6-(hydroxymethyl)-3,4-bis({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})oxan-2-yl]oxy}-6-(hydroxymethyl)oxan-2-yl]oxy}-15'-hydroxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-11'-en-10'-one
(1's,2r,2's,4's,5r,7's,8'r,9's,13's,15'r,16'r,18's)-16'-{[(2r,3r,4r,5r,6r)-3,4-dihydroxy-5-{[(2s,3r,4s,5r,6r)-5-hydroxy-6-(hydroxymethyl)-3,4-bis({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})oxan-2-yl]oxy}-6-(hydroxymethyl)oxan-2-yl]oxy}-15'-hydroxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-11'-en-10'-one
16'-[(3,4-dihydroxy-5-{[5-hydroxy-6-(hydroxymethyl)-3,4-bis({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})oxan-2-yl]oxy}-6-(hydroxymethyl)oxan-2-yl)oxy]-15'-hydroxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-11'-en-10'-one
16'-[(3,4-dihydroxy-5-{[5-hydroxy-6-(hydroxymethyl)-3,4-bis({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})oxan-2-yl]oxy}-6-(hydroxymethyl)oxan-2-yl)oxy]-15'-hydroxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-11'-en-10'-one
(2s)-n-[(2s,5s,8s,11r,12s,15s,18s,21r)-8-[(2r)-butan-2-yl]-15-(3-carbamimidamidopropyl)-6,13,16,21-tetrahydroxy-2-[(1r)-1-hydroxyethyl]-5-[(4-hydroxyphenyl)methyl]-4,11-dimethyl-3,9,22-trioxo-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2-{[(2r)-1,2-dihydroxy-3-(sulfooxy)propylidene]amino}-3-(4-hydroxyphenyl)propanimidic acid
(2s)-n-[(2s,5s,8s,11r,12s,15s,18s,21r)-8-[(2r)-butan-2-yl]-15-(3-carbamimidamidopropyl)-6,13,16,21-tetrahydroxy-2-[(1r)-1-hydroxyethyl]-5-[(4-hydroxyphenyl)methyl]-4,11-dimethyl-3,9,22-trioxo-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2-{[(2r)-1,2-dihydroxy-3-(sulfooxy)propylidene]amino}-3-(4-hydroxyphenyl)propanimidic acid
C47H68N10O18S (1092.4433548000002)